Triple Antibiotic (Unifirst First Aid Corporation)


Welcome to the PulseAid listing for the Triple Antibiotic drug offered from Unifirst First Aid Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Unifirst First Aid Corporation
NON-PROPRIETARY NAME: bacitracin zinc, neomycin sulfate, polymyxin b sulfate, lidocaine
SUBSTANCE NAME: BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; LIDOCAINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: OINTMENT
MARKETING CATEGORY NAME: OTC MONOGRAPH NOT FINAL
START MARKETING DATE: 2013-09-20
END MARKETING DATE: 2018-08-01


Triple Antibiotic HUMAN OTC DRUG Details:

Item DescriptionTriple Antibiotic from Unifirst First Aid Corporation
LABELER NAME: Unifirst First Aid Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 400; 3.5; 5000; 40([USP’U]/g; mg/g; [USP’U]/g; mg/g)
START MARKETING DATE: 2013-09-20
END MARKETING DATE: 2018-08-01
PRODUCT ID: 47682-935_53337fde-6b7f-0564-e054-00144ff88e88
PRODUCT NDC: 47682-935
APPLICATION NUMBER: part348

Other BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; LIDOCAINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Unifirst First Aid CorporationTriple Antibiotic